-------------------------------------------------------------------------------- | | Copenhagen, 16 June 2008 | -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- Novo Nordisk A/S - reduction in share capital by cancelling own shares The B share capital of the following share will be reduced with effect from 20 June 2008: -------------------------------------------------------------------------------- | ISIN | Name | -------------------------------------------------------------------------------- | DK0060102614 | Novo Nordisk B | -------------------------------------------------------------------------------- On 12 March 2008, the ordinary general meeting in Novo Nordisk adopted to reduce the B share capital by cancelling own shares. For further information, please see announcements published by Novo Nordisk, e.g. announcement of 13 June 2008. ISIN: DK0060102614 (VP: 6010261) -------------------------------------------------------------------------------- | Name: | Novo Nordisk B | -------------------------------------------------------------------------------- | Volume before change: | 539,472,800 shares (DKK 539,472,800) | -------------------------------------------------------------------------------- | Change: | 12,960,000 shares (DKK 12,690,000) | -------------------------------------------------------------------------------- | Volume after change: | 526,512,800 shares (DKK 526,512,800) | -------------------------------------------------------------------------------- | Face value: | DKK 1 | -------------------------------------------------------------------------------- | Short name: | NOVO B | -------------------------------------------------------------------------------- | Changed trading lot: | 50 | -------------------------------------------------------------------------------- For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66
Novo Nordisk A/S - reduction in share capital by cancelling own shares
| Source: Nasdaq Copenhagen A/S
Attachments
